Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the advantages or disadvantages of long term treatment in patients with type 2 diabetes mellitus with long acting insulin analogues currently insulin glargine and insulin detemir compared to NPH Insulin (isophane insulin human).